PNTG Pennant Group, Inc.
Services-Health Services · Nasdaq · SEC CIK 1766400 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY38.7%
TTM net income YoY34.4%
TTM EPS YoY34.7%
Revenue 3-yr CAGR30.9%
Net income 3-yr CAGR42.1%
Margins
Gross margin18.3%
Operating margin5.8%
Net margin3.1%
FCF margin2.9%
EBITDA margin6.8%
Returns
ROE10.3%
ROA4.0%
ROIC (approx.)11.3%
Asset turnover1.31x
Leverage & solvency
Liabilities / assets59.7%
Debt / equity0.53x
Current ratio1.18x
Interest coverage5.15x
Cash quality & payout
Operating cash flow / net income1.80x
Accruals ratio-3.2%
Payout ratio—
Capex / revenue2.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $947.71M | $695.24M | $544.89M | $473.24M | $439.69M |
| Cost of revenue | $768.50M | $558.45M | $438.10M | $376.64M | $350.24M |
| Gross profit | $179.20M | $136.79M | $106.80M | $96.60M | $89.46M |
| SG&A expense | $71.08M | $50.21M | $36.67M | $33.98M | $36.26M |
| Operating income | $51.89M | $38.12M | $25.17M | $12.74M | $4.70M |
| Interest expense | $6.68M | $6.96M | $5.92M | $3.82M | $1.94M |
| Pretax income | $45.63M | $31.37M | $19.58M | $8.89M | $2.73M |
| Income tax | $11.87M | $7.03M | $5.67M | $1.65M | $582,000 |
| Net income | $29.58M | $22.56M | $13.38M | $6.64M | $2.70M |
| EBITDA | $60.42M | $44.23M | $30.30M | $17.64M | $9.48M |
| EPS (basic) | 0.86 | 0.72 | 0.45 | 0.23 | 0.09 |
| EPS (diluted) | 0.84 | 0.70 | 0.44 | 0.22 | 0.09 |
| Weighted avg. shares (diluted) | 35.32M | 32.00M | 30.19M | 30.16M | 30.64M |
| Balance sheet | |||||
| Cash & equivalents | $17.02M | $24.25M | $6.06M | $2.08M | $5.19M |
| Receivables | $123.11M | $81.30M | $61.12M | $53.42M | $53.94M |
| Current assets | $167.41M | $122.86M | $80.08M | $73.82M | $75.84M |
| PP&E, net | $60.98M | $43.30M | $28.60M | $26.62M | $16.79M |
| Goodwill | $237.25M | $129.12M | $91.01M | $79.50M | $74.27M |
| Total assets | $968.18M | $679.52M | $539.69M | $512.12M | $530.30M |
| Current liabilities | $147.26M | $101.70M | $71.55M | $70.25M | $71.64M |
| Short-term debt | $5.00M | $0 | — | — | — |
| Long-term debt | $168.84M | $0 | $63.91M | $62.89M | $51.37M |
| Total debt | $173.84M | $0 | $63.91M | $62.89M | $51.37M |
| Total liabilities | $593.93M | $367.56M | $394.18M | $386.46M | $416.05M |
| Shareholders' equity | $332.60M | $293.28M | $140.34M | $121.01M | $110.20M |
| Net debt | $156.81M | -$24.25M | $57.85M | $60.81M | $46.18M |
| Shares outstanding | 34.63M | 34.37M | 29.95M | 29.69M | 28.50M |
| Cash flow statement | |||||
| Operating cash flow | $48.29M | $39.30M | $33.09M | $9.04M | -$18.22M |
| Capital expenditure | $12.04M | $8.99M | $8.11M | $14.17M | $6.30M |
| Free cash flow | $36.26M | $30.31M | $24.98M | -$5.13M | -$24.53M |
| Investing cash flow | -$227.97M | -$70.68M | -$30.22M | -$24.24M | -$20.12M |
| Financing cash flow | $172.46M | $49.57M | $1.11M | $12.08M | $43.49M |
| Depreciation & amortization | $8.54M | $6.12M | $5.13M | $4.90M | $4.78M |
| Stock-based compensation | $8.94M | $7.78M | $5.37M | $3.09M | $10.04M |
| Dividends paid | — | — | — | — | $0 |
| Share buybacks | — | — | — | $0 | $0 |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.